(HBM) Hudbay Minerals - Ratings and Ratios

Exchange: NYSE • Country: Canada • Currency: USD • Type: Common Stock • ISIN: CA4436281022

Copper, Gold, Silver, Zinc, Molybdenum

Stock: Diversified Metals & Mining
Age 16.9y

MCap 9,016m
Avg Vol 4.00M (85.4M USD)

Beta 1.446
Volatility 47.61%

EPS (Earnings per Share)

EPS CAGR: -5.97%
EPS Trend: 34.9%

Last SUE: -3.31
Qual. Beats: 0

Revenue

Rev. CAGR: -5.29%
Rev. Trend: 48.0%

Last SUE: -0.91
Qual. Beats: 0

Dividends

Dividend Yield	0.16%
Yield on Cost 5y	0.23%
Yield CAGR 5y	-3.28%
Payout Consistency	87.5%
Payout Ratio	2.2%

Risk via 5d forecast
Volatility	47.6%
Value at Risk 5%th	70.6%
Relative Tail Risk	-9.91%

Reward TTM
Sharpe Ratio	2.06
Alpha	159.06
CAGR/Max DD	1.49

Character TTM
Hurst Exponent	0.487
Beta	1.446
Beta Downside	1.503

Drawdowns 3y
Max DD	41.10%
Mean DD	13.31%
Median DD	12.47%

Description: HBM Hudbay Minerals January 10, 2026

Hudbay Minerals Inc. (NYSE: HBM) is a Toronto-based, diversified mining firm operating primarily in North and South America. Its core business spans exploration, development, production, and optimization of base-metal assets, with a product mix that includes copper concentrates (copper, gold, silver), silver/gold doré, zinc concentrates (zinc, gold), and molybdenum concentrates. The flagship Constancia mine in Cusco, Peru, drives the majority of its copper output.

Key operational metrics (FY 2024) show Constancia delivering ~300 kt of copper concentrate at an average cash cost of ~$1.70 lb Cu, while the company’s zinc operations contributed ~120 kt of zinc concentrate with a cash cost near $0.85 lb Zn. Hudbay’s free cash flow was roughly $300 M, supported by a 12 % year-over-year rise in copper prices (≈ $4.30 lb) and a stable zinc price environment (≈ $1.30 lb). A sector driver to watch is the ongoing supply deficit in copper, which underpins demand-side pricing pressure and could enhance Hudbay’s margin outlook.

For a deeper quantitative view of Hudbay’s valuation and risk profile, consider reviewing its data on ValueRay.

Piotroski VR‑10 (Strict, 0-10) 6.0

Net Income: 461.7m TTM > 0 and > 6% of Revenue
FCF/TA: 0.05 > 0.02 and ΔFCF/TA -0.52 > 1.0
NWC/Revenue: -1.68% < 20% (prev 21.31%; Δ -22.99% < -1%)
CFO/TA 0.13 > 3% & CFO 740.1m > Net Income 461.7m
Net Debt (497.1m) to EBITDA (1.28b): 0.39 < 3
Current Ratio: 0.97 > 1.5 & < 3
Outstanding Shares: last quarter (396.9m) vs 12m ago 0.67% < -2%
Gross Margin: 37.80% > 18% (prev 0.34%; Δ 3746 % > 0.5%)
Asset Turnover: 36.11% > 50% (prev 37.01%; Δ -0.89% > 0%)
Interest Coverage Ratio: 11.48 > 6 (EBITDA TTM 1.28b / Interest Expense TTM 75.5m)

Altman Z'' (< 1.1 .. > 2.6) 2.31

A: -0.01 (Total Current Assets 994.3m - Total Current Liabilities 1.03b) / Total Assets 5.92b
B: 0.06 (Retained Earnings 332.5m / Total Assets 5.92b)
C: 0.15 (EBIT TTM 867.5m / Avg Total Assets 5.71b)
D: 1.09 (Book Value of Equity 3.08b / Total Liabilities 2.84b)
Altman-Z'' Score: 2.31 = BBB

ValueRay F-Score (Strict, 0-100) 74.26

1. Piotroski: 6.0pt
2. FCF Yield: 3.33%
3. FCF Margin: 15.38%
4. Debt/Equity: 0.36
5. Debt/Ebitda: 0.39
6. ROIC - WACC: 4.96%
7. RoE: 16.56%
8. Revenue Trend: 48.03%
9. EPS Trend: 34.94%

What is the price of HBM shares?

As of January 23, 2026, the stock is trading at USD 24.05 with a total of 9,600,445 shares traded.
Over the past week, the price has changed by +4.16%, over one month by +21.96%, over three months by +58.02% and over the past year by +173.74%.

Is HBM a buy, sell or hold?

Hudbay Minerals has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy HBM.

Strong Buy: 8
Buy: 8
Hold: 0
Sell: 0
Strong Sell: 0

What are the forecasts/targets for the HBM price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	22.2	-7.7%
Analysts Target Price	22.2	-7.7%
ValueRay Target Price	32.3	34.2%

HBM Fundamental Data Overview January 17, 2026

P/E Trailing = 19.6207
P/E Forward = 18.5529
P/S = 4.3705
P/B = 2.9693
P/EG = 2.09
Revenue TTM = 2.06b USD
EBIT TTM = 867.5m USD
EBITDA TTM = 1.28b USD
Long Term Debt = 536.0m USD (from longTermDebt, last quarter)
Short Term Debt = 540.9m USD (from shortTermDebt, last quarter)
Debt = 1.11b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 497.1m USD (from netDebt column, last quarter)
Enterprise Value = 9.51b USD (9.02b + Debt 1.11b - CCE 611.1m)
Interest Coverage Ratio = 11.48 (Ebit TTM 867.5m / Interest Expense TTM 75.5m)
EV/FCF = 29.99x (Enterprise Value 9.51b / FCF TTM 317.3m)
FCF Yield = 3.33% (FCF TTM 317.3m / Enterprise Value 9.51b)
FCF Margin = 15.38% (FCF TTM 317.3m / Revenue TTM 2.06b)
Net Margin = 22.38% (Net Income TTM 461.7m / Revenue TTM 2.06b)
Gross Margin = 37.80% ((Revenue TTM 2.06b - Cost of Revenue TTM 1.28b) / Revenue TTM)
Gross Margin QoQ = 18.83% (prev 32.90%)
Tobins Q-Ratio = 1.61 (Enterprise Value 9.51b / Total Assets 5.92b)
Interest Expense / Debt = 1.62% (Interest Expense 18.0m / Debt 1.11b)
Taxrate = 32.71% (108.1m / 330.5m)
NOPAT = 583.7m (EBIT 867.5m * (1 - 32.71%))
Current Ratio = 0.97 (Total Current Assets 994.3m / Total Current Liabilities 1.03b)
Debt / Equity = 0.36 (Debt 1.11b / totalStockholderEquity, last quarter 3.08b)
Debt / EBITDA = 0.39 (Net Debt 497.1m / EBITDA 1.28b)
Debt / FCF = 1.57 (Net Debt 497.1m / FCF TTM 317.3m)
Total Stockholder Equity = 2.79b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.08% (Net Income 461.7m / Total Assets 5.92b)
RoE = 16.56% (Net Income TTM 461.7m / Total Stockholder Equity 2.79b)
RoCE = 26.10% (EBIT 867.5m / Capital Employed (Equity 2.79b + L.T.Debt 536.0m))
RoIC = 15.09% (NOPAT 583.7m / Invested Capital 3.87b)
WACC = 10.13% (E(9.02b)/V(10.12b) * Re(11.24%) + D(1.11b)/V(10.12b) * Rd(1.62%) * (1-Tc(0.33)))
Discount Rate = 11.24% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 6.62%
[DCF Debug] Terminal Value 74.66% ; FCFF base≈319.9m ; Y1≈394.6m ; Y5≈672.0m
Fair Price DCF = 18.71 (EV 7.91b - Net Debt 497.1m = Equity 7.41b / Shares 396.1m; r=10.13% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 34.94 | EPS CAGR: -5.97% | SUE: -3.31 | # QB: 0
Revenue Correlation: 48.03 | Revenue CAGR: -5.29% | SUE: -0.91 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.42 | Chg30d=+0.076 | Revisions Net=+2 | Analysts=7
EPS next Year (2026-12-31): EPS=1.49 | Chg30d=+0.106 | Revisions Net=+5 | Growth EPS=+59.2% | Growth Revenue=+19.4%

Additional Sources for HBM Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle